Table 1.
Participant characteristics and clinical information related to the hospital stay for COVID-19.
| Characteristic |
Total (N = 84) |
|---|---|
| Baseline and demographic data | |
| Age (years), median (IQR) | 50 (38–65) |
| Male, n (%) | 59 (70.2) |
| Height (cm), median (IQR) | 167.8 (162.2–173.9) |
| Weight (kg), median (IQR) | 67.1 (59–75.5) |
| BMI, median (IQR) | 24 (21.3–26.4) |
| Medical history and smoking status | |
| Hypertension, n (%) | 27 (32.1) |
| DM, n (%) | 18 (21.4) |
| Hyperlipidemia, n (%) | 20 (23.8) |
| Smoker, n (%) | 32 (38.1) |
| COPD, n (%) | 5 (6.0) |
| Myocardial Infarction, n (%) | 1 (1.2) |
| Arrhythmia, n (%) | 7 (8.3) |
| Medications | |
| ACEI/ARB, n (%) | 14 (16.7) |
| Beta-blocker, n (%) | 8 (9.5) |
| During hospital stay | |
| Oxygen inhalation, n (%) | 35 (41.7) |
| Presence of pneumonia, n (%) | 71 (84.5) |
| Mechanical ventilation, n (%) | 15 (17.9) |
| Glucocorticoid use, n (%) | 24 (28.6) |
| Peak body temperature, median (IQR) | 38.5 (37.6–39) |
| Maximum CRP, Median (IQR) | 6.8 (1.7–16.3) |
| Maximum LDH, Median (IQR) | 304 (241–467.8) |
| Maximum fibrinogen, median (IQR) | 548 (381–654) |
| Maximum D-dimer, median (IQR) | 0.8 (0.5–2.3) |
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; DM, diabetes mellitus; IQR, interquartile range; LDH, lactate dehydrogenase.